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Appendix 1. Equations for calculating renal function
Cockcroft–Gault equation using actual body weight (CG-ABW)
Adult males: CrCl = (140 – age [years]) × weight (kg) × 1.23
                                                                 Serum creatinine (µmol/L)
Adult females: CrCl = (140 – age [years]) × weight (kg) × 1.04
                                                                        Serum creatinine (µmol/L)
Modified Cockcroft–Gault equation (modified CG)
Adult males: CrCl = (140 – age [years]) × 90
                                                                 SCr (µmol/L)
                 Adult females:           CrCl = (140 – age [years]) × 90
                                                                       SCr (µmol/L)
Appendix 2. Dosing recommendations based on Canadian drug monographs
Apixaban10
•  5 mg BID or
•  2.5 mg BID if TWO or more of the following apply: age ≥ 80 years, body weight ≤ 60 kg, SCr ≥ 133 µmol/L 
•  Not recommended if CrCl < 25 mL/min
Dabigatran9
•  150 mg BID or
•  110 mg BID if age ≥ 80 years; consider this dose if age > 75 years and CrCl 30–49 mL/min
•  Not recommended if CrCl < 30 mL/min
Rivaroxaban8
•  20 mg once daily if CrCl ≥ 50 mL/min or
•  15 mg once daily if CrCl 30–49 mL/min
•  Not recommended if CrCl < 30 mL/min
Appendix 3. Criteria for comparison of dosing determined by Cockcroft–Gault equation based on actual body weight (CG-ABW)
and by modified Cockcroft–Gault (CG) equation 
Dosing is appropriate if:
•  CG-ABW and modified CG equations resulted in the same dosing recommendation
Dosing is supratherapeutic if: 
•  CG-ABW equation resulted in the same dosing recommendation at discharge, but modified CG equation resulted in recommendation 
   for a higher dose at discharge
•  CG-ABW equation resulted in recommendation for a lower dose at discharge, but modified CG equation resulted in the same dosing 
   recommendation at discharge
•  CG-ABW equation resulted in recommendation against use of direct oral anticoagulant at discharge (based on renal function), 
   but modified CG equation resulted in a recommendation for any dose at discharge
Dosing is subtherapeutic if:
•  CG-ABW equation resulted in recommendation for a higher dose at discharge, but modified CG equation resulted in the same dosing 
   recommendation at discharge
•  CG-ABW equation resulted in recommendation for same dose at discharge, but modified CG equation resulted in recommendation 
   for lower dose at discharge
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